Isocitrate dehydrogenase (IDH) inhibitors

DBCAT005991Pharmacologic classL01XM

A DrugBank category of 4 drugs. 4 of them are approved.

ATC classification: L — ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
L01 — ANTINEOPLASTIC AGENTS
L01X — OTHER ANTINEOPLASTIC AGENTS
L01XM — Isocitrate dehydrogenase (IDH) inhibitors
Drugs: Enasidenib
Ivosidenib
Olutasidenib
Vorasidenib

What you can answer from here — as of May 01, 2025

4DrugsEach linked to its full drug card

Listed above

6Drug targetsEvery drug–target pair in the class, with bond type

16Marketed productsAcross the regions we cover, with dosage forms and routes

1Route of administrationHow the drugs in this class are given

Which targets do Isocitrate dehydrogenase (IDH) inhibitors share, and which companies have late-stage candidates in this class?

Create a free account or log in to explore the full data card.